Overall survival (OS) · newly‐diagnosed EOC
Summary of findings table ‐ Newly‐diagnosed EOC: PARPi monotherapy showed no clear difference in overall survival (OS) compared with placebo (maintenance therapy) (moderate certainty).
1 finding from 1 review
Progression‐free survival · newly‐diagnosed EOC
Summary of findings table ‐ Newly‐diagnosed EOC: PARPi monotherapy may leads to lower progression‐free survival (PFS) compared with placebo (maintenance therapy) (low certainty).
1 finding from 1 review
QoL · newly‐diagnosed EOC
1 finding from 1 review
Fatigue –concentration problems Subscale from CIS · people with a primary brain tumour
1 finding from 1 review
Cognition Semantic Fluency · people with a primary brain tumour
1 finding from 1 review
Cognition Lexical Fluency · people with a primary brain tumour
1 finding from 1 review
Cognitive subdomain: episodic memory measured at the end of · people with a primary brain tumour
1 finding from 1 review
Cognitive function · people with a primary brain tumour
1 finding from 1 review
Affectivity Norris Scale · people with a primary brain tumour
1 finding from 1 review
Apathy Marin Scale · people with a primary brain tumour
1 finding from 1 review
Depressive symptoms · people with a primary brain tumour
1 finding from 1 review
Health‐related quality of life European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ‐C30). Scale from: 0 to 100 (a higher score means a better outcome) · people with a primary brain tumour
1 finding from 1 review
Quality of life EORTC QLQ‐BN 20 · people with a primary brain tumour
1 finding from 1 review
Fatigue · people with a primary brain tumour
1 finding from 1 review
Fatigue –reduced motivation Subscale from CIS · people with a primary brain tumour
1 finding from 1 review
Cognition Symbol Digit Modalities Test (median (range)) · people with a primary brain tumour
1 finding from 1 review
Quality of life, self‐rated at post‐treatment · people with a primary brain tumour
1 finding from 1 review
Adverse events (grade ≥ 3) · people with a primary brain tumour
1 finding from 1 review
Fatigue –reduced activity Subscale from CIS · people with a primary brain tumour
1 finding from 1 review
Fatigue –severity Subscale from CIS · people with a primary brain tumour
1 finding from 1 review